Sumitomo Mitsui Trust Group’s Sabra Healthcare REIT SBRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $61.7M | Buy |
3,208,600
+203,226
| +7% | +$4M | 0.04% | 382 |
|
|
2025
Q4 | $56.9M | Buy |
3,005,374
+2,736,993
| +1,020% | +$50.7M | 0.03% | 427 |
|
|
2025
Q3 | $5M | Buy |
268,381
+7,076
| +3% | +$132K | ﹤0.01% | 737 |
|
|
2025
Q2 | $4.82M | Buy |
261,305
+3,405
| +1% | +$60.4K | ﹤0.01% | 721 |
|
|
2025
Q1 | $4.51M | Buy |
257,900
+2,790
| +1% | +$47K | ﹤0.01% | 738 |
|
|
2024
Q4 | $4.42M | Buy |
255,110
+2,109
| +0.8% | +$38.5K | ﹤0.01% | 755 |
|
|
2024
Q3 | $4.71M | Sell |
253,001
-1,663
| -0.7% | -$28K | ﹤0.01% | 759 |
|
|
2024
Q2 | $3.92M | Sell |
254,664
-7,307
| -3% | -$104K | ﹤0.01% | 764 |
|
|
2024
Q1 | $3.87M | Sell |
261,971
-886,675
| -77% | -$12.3M | ﹤0.01% | 838 |
|
|
2023
Q4 | $16.4M | Sell |
1,148,646
-408,148
| -26% | -$5.8M | 0.01% | 728 |
|
|
2023
Q3 | $21.7M | Sell |
1,556,794
-707,599
| -31% | -$9.05M | 0.02% | 680 |
|
|
2023
Q2 | $26.7M | Sell |
2,264,393
-133,691
| -6% | -$1.52M | 0.02% | 645 |
|
|
2023
Q1 | $27.6M | Buy |
2,398,084
+585,125
| +32% | +$7.24M | 0.02% | 658 |
|
|
2022
Q4 | $22.5M | Buy |
1,812,959
+256,215
| +16% | +$3.27M | 0.02% | 692 |
|
|
2022
Q3 | $20.4M | Sell |
1,556,744
-59,775
| -4% | -$883K | 0.02% | 699 |
|
|
2022
Q2 | $22.6M | Buy |
1,616,519
+1,315,648
| +437% | +$17.6M | 0.02% | 697 |
|
|
2022
Q1 | $4.48M | Sell |
300,871
-12,033
| -4% | -$165K | ﹤0.01% | 866 |
|
|
2021
Q4 | $4.24M | Sell |
312,904
-1,981,160
| -86% | -$28M | ﹤0.01% | 847 |
|
|
2021
Q3 | $33.8M | Buy |
2,294,064
+82,137
| +4% | +$1.39M | 0.02% | 634 |
|
|
2021
Q2 | $40.3M | Buy |
2,211,927
+1,872,626
| +552% | +$33.3M | 0.02% | 603 |
|
|
2021
Q1 | $5.89M | Sell |
339,301
-27,761
| -8% | -$488K | ﹤0.01% | 829 |
|
|
2020
Q4 | $6.38M | Sell |
367,062
-609,985
| -62% | -$9.73M | ﹤0.01% | 814 |
|
|
2020
Q3 | $13.5M | Sell |
977,047
-115,365
| -11% | -$1.69M | 0.01% | 729 |
|
|
2020
Q2 | $15.8M | Buy |
1,092,412
+674,250
| +161% | +$8.86M | 0.01% | 708 |
|
|
2020
Q1 | $4.57M | Buy |
418,162
+77,160
| +23% | +$1.42M | ﹤0.01% | 795 |
|
|
2019
Q4 | $7.28M | Buy |
341,002
+88,449
| +35% | +$1.98M | 0.01% | 768 |
|
|
2019
Q3 | $5.8M | Buy |
252,553
+43,927
| +21% | +$937K | 0.01% | 771 |
|
|
2019
Q2 | $4.11M | Buy |
208,626
+94,551
| +83% | +$1.84M | ﹤0.01% | 782 |
|
|
2019
Q1 | $2.22M | Sell |
114,075
-70,097
| -38% | -$1.33M | ﹤0.01% | 780 |
|
|
2018
Q4 | $3.02M | Buy |
184,172
+1,237
| +0.7% | +$24.9K | ﹤0.01% | 726 |
|
|
2018
Q3 | $4.23M | Buy |
182,935
+717
| +0.4% | +$16.2K | ﹤0.01% | 716 |
|
|
2018
Q2 | $3.96M | Buy |
182,218
+11,576
| +7% | +$226K | ﹤0.01% | 723 |
|
|
2018
Q1 | $3.01M | Buy |
170,642
+8,935
| +6% | +$157K | ﹤0.01% | 738 |
|
|
2017
Q4 | $3.04M | Buy |
161,707
+9,063
| +6% | +$180K | ﹤0.01% | 742 |
|
|
2017
Q3 | $3.35M | Buy |
152,644
+90,093
| +144% | +$2.04M | ﹤0.01% | 724 |
|
|
2017
Q2 | $1.51M | Hold |
62,551
| – | – | ﹤0.01% | 769 |
|
|
2017
Q1 | $1.75M | Buy |
62,551
+421
| +0.7% | +$11K | ﹤0.01% | 741 |
|
|
2016
Q4 | $1.52M | Buy |
62,130
+15,781
| +34% | +$362K | ﹤0.01% | 752 |
|
|
2016
Q3 | $1.17M | Sell |
46,349
-163
| -0.4% | -$3.9K | ﹤0.01% | 760 |
|
|
2016
Q2 | $960K | Sell |
46,512
-259
| -0.6% | -$5.4K | ﹤0.01% | 764 |
|
|
2016
Q1 | $940K | Buy |
46,771
+219
| +0.5% | +$4.2K | ﹤0.01% | 787 |
|
|
2015
Q4 | $958K | Sell |
46,552
-301
| -0.6% | -$6.34K | ﹤0.01% | 786 |
|
|
2015
Q3 | $1.09M | Buy |
46,853
+5,546
| +13% | +$142K | ﹤0.01% | 770 |
|
|
2015
Q2 | $1.06M | Buy |
41,307
+3,646
| +10% | +$104K | ﹤0.01% | 792 |
|
|
2015
Q1 | $1.25M | Buy |
37,661
+569
| +2% | +$18.5K | ﹤0.01% | 764 |
|
|
2014
Q4 | $1.15M | Buy |
37,092
+243
| +0.7% | +$6.7K | ﹤0.01% | 772 |
|
|
2014
Q3 | $896K | Buy |
36,849
+4,822
| +15% | +$134K | ﹤0.01% | 770 |
|
|
2014
Q2 | $919K | Buy |
32,027
+5,628
| +21% | +$164K | ﹤0.01% | 723 |
|
|
2014
Q1 | $736K | Buy |
26,399
+3,253
| +14% | +$89.4K | ﹤0.01% | 720 |
|
|
2013
Q4 | $606K | Sell |
23,146
-1,256
| -5% | -$32.4K | ﹤0.01% | 733 |
|
|
2013
Q3 | $561K | Sell |
24,402
-897
| -4% | -$22.1K | ﹤0.01% | 724 |
|
|
2013
Q2 | $661K | Buy |
+25,299
| New | +$730K | ﹤0.01% | 703 |
|
Other funds holding SBRA
VPM
VCM
N
Sumitomo Mitsui Trust Group's SBRA Position: Q1 2026 in Review
Sumitomo Mitsui Trust Group increased its Sabra Healthcare REIT (SBRA) stake by 6.8% in Q1 2026, buying an estimated $4M and bringing the position to 3,208,600 shares worth $61.7M. The position accounts for 0.04% of the portfolio, ranked #382.
Sumitomo Mitsui Trust Group first reported a position in SBRA in Q2 2013 and has held it in 52 quarters since. 459 funds tracked by Wall St. Rank hold SBRA as of Q1 2026.
- Sumitomo Mitsui Trust Group held 3,208,600 shares of Sabra Healthcare REIT worth $61.7M as of Q1 2026.
- Sumitomo Mitsui Trust Group bought 203,226 Sabra Healthcare REIT shares in Q1 2026, an estimated $4M.
- Sabra Healthcare REIT made up 0.04% of Sumitomo Mitsui Trust Group's portfolio in Q1 2026, its #382 holding.
- Sumitomo Mitsui Trust Group first reported a position in Sabra Healthcare REIT in Q2 2013 and has held it in 52 quarters since.
- 459 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2026.
Based on Sumitomo Mitsui Trust Group's 13F filing for Q1 2026, filed 30 Apr 2026.